Level Biotechnology Inc.

TPEX:3118 Stock Report

Market Cap: NT$1.1b

Level Biotechnology Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Level Biotechnology.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth17.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Some Investors May Be Worried About Level Biotechnology's (GTSM:3118) Returns On Capital

Apr 27
Some Investors May Be Worried About Level Biotechnology's (GTSM:3118) Returns On Capital

Calculating The Fair Value Of Level Biotechnology Inc. (GTSM:3118)

Mar 16
Calculating The Fair Value Of Level Biotechnology Inc. (GTSM:3118)

Here's What You Should Know About Level Biotechnology Inc.'s (GTSM:3118) 3.6% Dividend Yield

Feb 14
Here's What You Should Know About Level Biotechnology Inc.'s (GTSM:3118) 3.6% Dividend Yield

Does Level Biotechnology's (GTSM:3118) Returns On Capital Reflect Well On The Business?

Jan 24
Does Level Biotechnology's (GTSM:3118) Returns On Capital Reflect Well On The Business?

Level Biotechnology Inc.'s (GTSM:3118) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Jan 03
Level Biotechnology Inc.'s (GTSM:3118) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Calculating The Intrinsic Value Of Level Biotechnology Inc. (GTSM:3118)

Dec 16
Calculating The Intrinsic Value Of Level Biotechnology Inc. (GTSM:3118)

Here's Why We Think Level Biotechnology's (GTSM:3118) Statutory Earnings Might Be Conservative

Nov 28
Here's Why We Think Level Biotechnology's (GTSM:3118) Statutory Earnings Might Be Conservative

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Level Biotechnology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TPEX:3118 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2023661636370N/A
9/30/2023654606774N/A
6/30/2023633627076N/A
3/31/2023620645664N/A
12/31/2022593585865N/A
9/30/2022569577582N/A
6/30/20226016297104N/A
3/31/202263261135145N/A
12/31/202167768147156N/A
9/30/202172874117127N/A
6/30/202171670114123N/A
3/31/202170169101104N/A
12/31/2020672588183N/A
9/30/20206485099101N/A
6/30/2020641488486N/A
3/31/2020635478083N/A
12/31/201963947107109N/A
9/30/201964647127129N/A
6/30/2019651456870N/A
3/31/2019644415960N/A
12/31/2018629392427N/A
9/30/201861946410N/A
6/30/2018579452333N/A
3/31/2018583572131N/A
12/31/2017578686071N/A
9/30/201754372N/A48N/A
6/30/201753775N/A74N/A
3/31/201751265N/A87N/A
12/31/201651463N/A79N/A
9/30/201650461N/A101N/A
6/30/201652369N/A102N/A
3/31/201653078N/A109N/A
12/31/201552078N/A98N/A
9/30/201554085N/A104N/A
6/30/201552480N/A105N/A
3/31/201552677N/A110N/A
12/31/201453377N/A102N/A
9/30/201451571N/A117N/A
6/30/201453570N/A92N/A
3/31/201452766N/A92N/A
12/31/201352965N/A96N/A
9/30/201351659N/A73N/A
6/30/201349355N/A85N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 3118's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if 3118's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 3118's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 3118's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 3118's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 3118's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.